These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2780710

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.
    Mózes T, Heiligers JP, Tak CJ, Zijlstra FJ, Ben-Efraim S, Saxena PR, Bonta IL.
    J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577
    [Abstract] [Full Text] [Related]

  • 3. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models.
    Bahr T, Schaper U, Becker K, Lueddeckens G, Förster W, Scheuch DW, Grupe R.
    Prog Clin Biol Res; 1989 Nov; 301():229-33. PubMed ID: 2798447
    [No Abstract] [Full Text] [Related]

  • 4. Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alfa-mediated cytotoxicity on murine L929 tumor cells.
    Hunyadi J, Kenderessy AS, Duda E, Braquet P, Dobozy A.
    Mol Immunol; 1993 Apr; 30(6):517-9. PubMed ID: 7683748
    [Abstract] [Full Text] [Related]

  • 5. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.
    Braquet P, Hosford D, Koltz P, Guilbaud J, Paubert-Braquet M.
    Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107
    [Abstract] [Full Text] [Related]

  • 6. Lethal and non-lethal course of endotoxic shock is determined by interactions between tumor necrosis factor, platelet activating factor and eicosanoids.
    Mozes T, Ben-Efraim S, Bonta IL.
    Pathol Biol (Paris); 1992 Oct; 40(8):807-12. PubMed ID: 1484741
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteins.
    Paubert-Braquet M, Hosford D, Klotz P, Guilbaud J, Braquet P.
    J Lipid Mediat; 1990 Oct; 2 Suppl():S1-4. PubMed ID: 1966810
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
    Pons L, Droy-Lefaix MT, Braquet P, Buéno L.
    Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
    [Abstract] [Full Text] [Related]

  • 10. Enhanced human monocyte cytotoxicity by platelet-activating factor.
    Valone FH, Philip R, Debs RJ.
    Immunology; 1988 Aug; 64(4):715-8. PubMed ID: 3169845
    [Abstract] [Full Text] [Related]

  • 11. Platelet-activating factor induces the production of leukotrienes by human monocytes.
    Fauler J, Sielhorst G, Frölich JC.
    Biochim Biophys Acta; 1989 Sep 04; 1013(1):80-5. PubMed ID: 2790041
    [Abstract] [Full Text] [Related]

  • 12. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M, Ortíz A, Lerma JL, López-Armada MJ, Mampaso F, González E, Egido J.
    Lab Invest; 1994 Apr 04; 70(4):449-59. PubMed ID: 8176885
    [Abstract] [Full Text] [Related]

  • 13. Effect of platelet-activating factor on monocyte activation and production of tumor necrosis factor.
    Bonavida B, Mencia-Huerta JM, Braquet P.
    Int Arch Allergy Appl Immunol; 1989 Apr 04; 88(1-2):157-60. PubMed ID: 2707879
    [Abstract] [Full Text] [Related]

  • 14. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure.
    Koltai M, Pirotzky E, Braquet P.
    Nephrol Dial Transplant; 1994 Apr 04; 9 Suppl 4():69-72. PubMed ID: 7800272
    [No Abstract] [Full Text] [Related]

  • 15. Role of PAF and cytokines in microvascular tissue injury.
    Koltai M, Hosford D, Braquet P.
    J Lab Clin Med; 1992 May 04; 119(5):461-6. PubMed ID: 1316420
    [No Abstract] [Full Text] [Related]

  • 16. Endotoxin shock, kinin system and PAF-acether in the rat.
    Damas J, Remacle-Volon G, Adam A, Bourdon V.
    Adv Exp Med Biol; 1989 May 04; 247B():547-52. PubMed ID: 2610092
    [No Abstract] [Full Text] [Related]

  • 17. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments.
    Bahrami S, Redl H, Thurnher M, Vogl C, Paul E, Schiesser A, Schlag G.
    Prog Clin Biol Res; 1989 May 04; 308():931-6. PubMed ID: 2780740
    [No Abstract] [Full Text] [Related]

  • 18. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor.
    Ruis NM, Rose JK, Valone FH.
    Lipids; 1991 Dec 04; 26(12):1060-4. PubMed ID: 1668105
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of PAF-induced tPA release by KO-286011.
    Klöcking HP.
    Ann N Y Acad Sci; 1992 Dec 04; 667():202-3. PubMed ID: 1309038
    [No Abstract] [Full Text] [Related]

  • 20. The effect of the platelet-activating factor antagonist, BN 52021, on human natural killer cell-mediated cytotoxicity.
    Mandi Y, Farkas G, Koltai M, Beladi I, Mencia-Huerta JM, Braquet P.
    Immunology; 1989 Jul 04; 67(3):370-4. PubMed ID: 2759659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.